CureVac N.V.
CIK 0001809122
Revenue (TTM)
—
Q2 Jun 2025
Net Income (TTM)
€153.86M
+162.3% YoY
Q2 Jun 2025
EPS Diluted (TTM)
€0.69
+161.0% YoY
Q2 Jun 2025
Gross Margin
—
Q2 Jun 2025
Operating Margin
—
Q2 Jun 2025
Net Margin
—
Q2 Jun 2025
Free Cash Flow (TTM)
—
Q2 Jun 2025
Cash
€392.7M
Q2 Jun 2025
Total Debt
—
Q2 Jun 2025
Shares Outstanding
224.34M sh
Q2 Jun 2025
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.